NCT07180836 - Prevalence and Hematological Characteristics of Hemoglobinopathies | Biotech Hunter

Enrollment

839

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

January 15, 2023

Study Completion Date

January 20, 2023

Conditions

Hemoglobinopathies

Interventions

OTHER

No Intervention (Observational Study)

This is an observational, cross-sectional study. Patients with suspected or confirmed hemoglobinopathies were evaluated for prevalence and hematological characteristics using laboratory investigations, without any experimental treatment or therapeutic intervention applied.

Trial Locations (1)

23200

Mardan Medical Comlex, Mardan, Mardan